In a genome-wide sequencing study from Iceland, rare loss-of-function variants in PTPN14 were associated with high risk of cervical cancer (OR, 12.7, p = 1.6 × 10−4) [123]. This evidence concerns the gene PTPN14 and cervical cancer.